InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by GARRITY THOMAS J, Director. Director active across 1 company, notably Antares Pharma, INC.. In total, 3 reports have been published. History available since 10 June 2021. The latest transaction was disclosed on 24 May 2022 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Thomas J. Garrity is a Board Member at Antares Pharma, Inc. He brings expertise in corporate strategy and product development. As a board member, he plays an active role in overseeing operations and guiding the strategic direction of the company, contributing to its ongoing success.